Conmed (CNMD) Non-Current Debt (2010 - 2026)

Conmed has reported Non-Current Debt for 17 years, with the latest figure at $860.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 3.51% year-over-year to $860.2 million; the trailing twelve-month figure through Mar 2026 stood at $860.2 million (down 3.51% YoY), and the FY2025 full-year result was $834.2 million, down 7.83% from the prior year.
• Non-Current Debt for Q1 2026 stood at $860.2 million, up from $834.2 million in the prior quarter.
• The five-year high for Non-Current Debt was $1.0 billion in Q3 2022, with the low at $703.5 million in Q1 2022.
• Historically, Non-Current Debt has averaged $924.1 million across 5 years, with a median of $942.2 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Debt surged 47.36% — and 2025, when it fell 9.97%.
• Conmed's Non-Current Debt stood at $985.1 million in 2022, then decreased by 1.21% to $973.1 million in 2023, then decreased by 7.0% to $905.1 million in 2024, then dropped by 7.83% to $834.2 million in 2025, then gained by 3.11% to $860.2 million in 2026.
• The last three Non-Current Debt figures came in at $860.2 million (Q1 2026), $834.2 million (Q4 2025), and $853.0 million (Q3 2025), per Business Quant data.